These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32563025)

  • 1. Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis.
    Wang Y; Ren R; Sun G; Peng L; Tian Y; Yang Y
    Int Immunopharmacol; 2020 Aug; 85():106661. PubMed ID: 32563025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis.
    Zhang T; Cui B; Li P; He Z; Long C; Wei L; Peng Z; Ji G; Zhang F
    PLoS One; 2016; 11(6):e0158227. PubMed ID: 27347881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
    Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
    Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis.
    Cui B; Li P; Xu L; Zhao Y; Wang H; Peng Z; Xu H; Xiang J; He Z; Zhang T; Nie Y; Wu K; Fan D; Ji G; Zhang F
    J Transl Med; 2015 Sep; 13():298. PubMed ID: 26363929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
    Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis.
    Ponce-Alonso M; García-Hoz C; Halperin A; Nuño J; Nicolás P; Martínez-Pérez A; Ocaña J; García-Pérez JC; Guerrero A; López-Sanromán A; Cantón R; Roy G; Del Campo R
    Front Immunol; 2021; 12():683387. PubMed ID: 34149723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.
    Wei Y; Gong J; Zhu W; Tian H; Ding C; Gu L; Li N; Li J
    BMC Microbiol; 2016 Nov; 16(1):255. PubMed ID: 27809778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siderophore-harboring gut bacteria and fecal siderophore genes for predicting the responsiveness of fecal microbiota transplantation for active ulcerative colitis.
    Yan J; Zhou G; Ren R; Zhang X; Zhang N; Wang Z; Peng L; Yang Y
    J Transl Med; 2024 Jun; 22(1):589. PubMed ID: 38915068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
    Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
    Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
    [No Abstract]   [Full Text] [Related]  

  • 11. Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.
    Tian Z; Liu J; Liao M; Li W; Zou J; Han X; Kuang M; Shen W; Li H
    Dig Dis Sci; 2016 Aug; 61(8):2262-2271. PubMed ID: 26846120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
    Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
    JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis.
    Singh A; Mahajan R; Kahlon BK; Dhaliwal AS; Midha V; Mehta V; Bansal N; Singh D; Sood A
    Indian J Gastroenterol; 2022 Aug; 41(4):389-396. PubMed ID: 36121613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.
    Moayyedi P; Surette MG; Kim PT; Libertucci J; Wolfe M; Onischi C; Armstrong D; Marshall JK; Kassam Z; Reinisch W; Lee CH
    Gastroenterology; 2015 Jul; 149(1):102-109.e6. PubMed ID: 25857665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiota Transplantation Ameliorates Active Ulcerative Colitis by Downregulating Pro-inflammatory Cytokines in Mucosa and Serum.
    Zhang WH; Jin ZY; Yang ZH; Zhang JY; Ma XH; Guan J; Sun BL; Chen X
    Front Microbiol; 2022; 13():818111. PubMed ID: 35444617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.
    Yan ZX; Gao XJ; Li T; Wei B; Wang PP; Yang Y; Yan R
    Appl Environ Microbiol; 2018 Jul; 84(14):. PubMed ID: 29728388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis.
    Huang C; Huang Z; Ding L; Fu Y; Fan J; Mei Q; Lou L; Wang J; Yin N; Lu Y; Guo S; Zeng Y
    J Transl Med; 2022 Aug; 20(1):354. PubMed ID: 35962454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study.
    Sood A; Mahajan R; Singh A; Midha V; Mehta V; Narang V; Singh T; Singh Pannu A
    J Crohns Colitis; 2019 Sep; 13(10):1311-1317. PubMed ID: 30873549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.